TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma (vol 37, pg 2215, 2017)
ONCOLOGY REPORTS（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined